Need professional-grade analysis? Visit stockanalysis.com
$2.84B
N/A
450
N/A
Price Chart
Risk-Adjusted Performance
Nordhealth AS (NORDH) Price Performance
Nordhealth AS (NORDH) trades on Oslo Stock Exchange in NOK. The company is classified in the Healthcare sector under the Health Information Services industry. The stock currently trades at NOK26.20, down 7.09% from the previous close.
Over the past year, NORDH has traded between a low of NOK26.20 and a high of NOK40.40. The stock has lost 32.5% over this period. It is currently 35.1% below its 52-week high.
Nordhealth AS has a market capitalization of $2.84B.
About Nordhealth AS
Nordhealth AS provides healthcare software solutions in Norway, Finland, Sweden, the United Kingdom, Denmark, Germany, and internationally. Its products include Provet Cloud, a veterinary practice management software (PMS); Diarium, a PMS for therapists that streamlines therapy sessions, booking, and invoicing; Physica, a PMS for physiotherapists; Psykbase, a PMS for psychologists and psychotherapists; EasyPractice, a PMS for therapists; and various PMS for veterinarians under the Vetserve, Sanimalis, Vetvision, and Vetera names. The company's products comprise Nordhealth Connect, a communication platform for patients and healthcare professionals; and Navisec, a digital learning environment for training and orientation. In addition, it offers services related to implementation of the SaaS systems, such as consultancy services, education, and data conversion. Further, the company provides nordhealth.fi, a consumer booking portal. Nordhealth AS was founded in 2001 and is based in Oslo, Norway.
Company Info
- Sector
- Healthcare
- Industry
- Health Information Services
- Exchange
- Oslo Stock Exchange
- Currency
- NOK
- Country
- Norway
Financial Metrics
- Revenue (TTM)
- $50.33M
- EBITDA
- $-2,801,000
- Profit Margin
- -21.21%
- EPS (TTM)
- -1.58
- Book Value
- 0.83
Technical Indicators
- 52 Week High
- NOK 40.60
- 52 Week Low
- NOK 24.20
- 50 Day MA
- NOK 35.39
- 200 Day MA
- NOK 37.05
- Beta
- 0.41
Valuation
- Trailing P/E
- N/A
- Forward P/E
- N/A
- Price/Sales
- 44.03
- Price/Book
- 3.22
- Enterprise Value
- $1.97B